Julie A Wolfson, Elizabeth S Davis, Aniket Saha, Isaac Martinez, David McCall, Prachi Kothari, Julienne Brackett, David S Dickens, Alissa R Kahn, Carla Schwalm, Archana Sharma, Joshua Richman, Branko Cuglievan, Smita Bhatia, Chen Dai, Jennifer M Levine, Emily E Johnston
Adolescents and Young Adults (AYAs: 15-39 y) with cancer face unique vulnerabilities, yet remain under-represented on clinical trials, including adult registries of COVID-19 in cancer (AYAs: 8-12%). Thus, we leveraged the Pediatric Oncology COVID-19 Case Report (POCC) to examine the clinical course of COVID-19 among AYAs with cancer. POCC collects de-identified clinical and sociodemographic data regarding 0-39yo with cancer (AYAs = 37%) and COVID-19 from >100 institutions. Between 04/01/2020-11/28/2023, 191 older AYAs [22-39y] and 640 younger AYAs [15-21y] were captured...
April 16, 2024: Journal of the National Cancer Institute